Schrödinger representives will be attending SMi’s 11th Annual Advances and Progress in Drug Design in London. At the conference, Schrödinger’s co-founder Professor Richard A. Friesner of Columbia University will be presenting “New computational techniques to enable lead discovery and lead optimization” on February 20th, 2012.
February 20th-21st, 2012
Schrödinger at SMi’s 11th Annual Advances and Progress in Drug Design Conference in London